Evaluation of Matrix Metalloproteinase 9 Serum Concentration as a Biomarker in Malignant Mesothelioma

BACKGROUND: Malignant mesothelioma (MM) is a rare, but fatal disease with few treatment options. The diagnosis and treatment response are challenging in MM. Therefore, the search for novel diagnostic and prognostic biomarkers is ongoing. The aim of our study was to investigate matrix metalloproteina...

Descripción completa

Detalles Bibliográficos
Autores principales: Štrbac, Danijela, Goričar, Katja, Dolžan, Vita, Kovač, Viljem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525906/
https://www.ncbi.nlm.nih.gov/pubmed/31191742
http://dx.doi.org/10.1155/2019/1242964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525906/
https://www.ncbi.nlm.nih.gov/pubmed/31191742
http://dx.doi.org/10.1155/2019/1242964

Ejemplares similares